Distinguished in Spinocerebellar Ataxia Type 14

Matthias Endres

Anna Louisa Karsch Str. 2, 
Berlin, BE, DE 
Distinguished in Spinocerebellar Ataxia Type 14
Anna Louisa Karsch Str. 2, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Matthias Endres practices in Berlin, Germany. Mr. Endres is rated as a Distinguished expert by MediFind in the treatment of Spinocerebellar Ataxia Type 14. His top areas of expertise are Stroke, Spinocerebellar Ataxia Type 14, Transient Ischemic Attack (TIA), Thrombectomy, and Cardiac Ablation.

His clinical research consists of co-authoring 601 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Spinocerebellar Ataxia Type 14.

Gender
Male

Locations

Anna Louisa Karsch Str. 2, Berlin, BE 10178, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
Depression and Posttraumatic Stress Disorder in Stroke Patients: an Observational Study of Neuro-psychiatric, Cognitive, and MR-Changes Over Time After Stroke
Depression and Posttraumatic Stress Disorder in Stroke Patients: an Observational Study of Neuro-psychiatric, Cognitive, and MR-Changes Over Time After Stroke
Enrollment Status: Completed
Publish Date: January 31, 2025
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Migraine and Endothelial Dysfunction
Migraine and Endothelial Dysfunction
Enrollment Status: Completed
Publish Date: July 18, 2018
View 3 Less Clinical Trials

601 Total Publications

Early management of mild ischaemic stroke: role of dual antiplatelet treatment.
Early management of mild ischaemic stroke: role of dual antiplatelet treatment.
Journal: European heart journal
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Endres's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 59 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile